Metronidazole-induced Neurotoxicity: Case Report

Descripción del Articulo

Metronidazole-induced neurotoxicity is an uncommon but underestimated complication in patients with prolonged exposure. We present the case of a 67-year-old male who presented with ataxia and seizures after receiving metronidazole and ceftriaxone for 65 days. The brain MRI showed typical lesions in...

Descripción completa

Detalles Bibliográficos
Autores: Cámara-Reyes, Ramon Rolando, Díaz-Carrión, Eddie G.
Formato: artículo
Fecha de Publicación:2025
Institución:Universidad Peruana Cayetano Heredia
Repositorio:Revistas - Universidad Peruana Cayetano Heredia
Lenguaje:español
OAI Identifier:oai:revistas.upch.edu.pe:article/5459
Enlace del recurso:https://revistas.upch.edu.pe/index.php/RMH/article/view/5459
Nivel de acceso:acceso abierto
Materia:Metronidazol
encefalopatías
imagen por resonancia magnética
toxicidad
Metronidazole
Brain Diseases
Magnetic Resonance Imaging
Toxicity
Descripción
Sumario:Metronidazole-induced neurotoxicity is an uncommon but underestimated complication in patients with prolonged exposure. We present the case of a 67-year-old male who presented with ataxia and seizures after receiving metronidazole and ceftriaxone for 65 days. The brain MRI showed typical lesions in the dentate nucleus, mesencephalon, and corpus callosum. Clinical and radiographic improvements were observed after stopping the antimicrobial. This case report emphasizes the importance of considering this entity in the differential diagnosis of neurologic derangement during prolonged antibiotic therapy, identifies MRI as a key diagnostic tool, and increases awareness to minimize serious adverse effects.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).